O Hwan Kwon
Overview
Explore the profile of O Hwan Kwon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
69
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kwon J, Kwon O, Jeong R, Kim N, Song S, Choi I, et al.
Anim Cells Syst (Seoul)
. 2021 Jul;
25(3):182-194.
PMID: 34262661
LBAL was developed as an adalimumab (Humira®) biosimilar using Chinese hamster ovary cell lines. Comparable quality, safety, and efficacy between a biosimilar and its reference product should be ensured for...
2.
Kwon O, Ha T, Kim D, Kim B, Kim Y, Shin T, et al.
ACS Appl Mater Interfaces
. 2018 Sep;
10(40):34625-34633.
PMID: 30216038
Controlling the anisotropy of two-dimensional materials with orientation-dependent heat transfer characteristics is a possible solution to resolve severe thermal issues in future electronic devices. We demonstrate a dramatic enhancement in...
3.
Ha S, Kwon O, Oh Y, Kim Y, Lee S, Won J, et al.
Sci Technol Adv Mater
. 2016 Nov;
16(6):065001.
PMID: 27877843
We explored the use of a hybrid filler consisting of graphite nanoplatelets (GNPs) and single walled carbon nanotubes (SWCNTs) in a polyamide 6 (PA 6) matrix. The composites containing PA...
4.
Kim S, Jung E, Yoon M, Kwon O, Hwang D, Kim D, et al.
Eur J Pharmacol
. 2016 Jun;
788:54-64.
PMID: 27298192
Gemigliptin, a novel dipeptidyl peptidase (DPP)-4 inhibitor, is approved for use as a monotherapy or in combination therapy to treat hyperglycemia in patients with type 2 diabetes mellitus. In this...
5.
Lee W, Hong C, Kwon O, Yoo Y, Kang Y, Lee J, et al.
ACS Appl Mater Interfaces
. 2015 Mar;
7(12):6550-6.
PMID: 25762308
The influence of processing conditions, such as ink concentration and coating method, on the thermoelectric properties of SWCNT/P3HT nanocomposite films was investigated systematically. Using simple wire-bar-coating, SWCNT/P3HT nanocomposite films with...
6.
Lee H, Kwon O, Ha S, Kim B, Kim Y, Won J, et al.
Phys Chem Chem Phys
. 2014 Aug;
16(37):20041-6.
PMID: 25123585
In this study, we investigated the thermal conductivities and mechanical properties of polyetherimide (PEI) composites using polyimide (PI)-coated h-BN (PI-BN) particles. We found that PI-coated h-BN effectively increased adhesion with...
7.
Lim K, Kim J, Choi Y, Shin K, Kim K, Hong J, et al.
Clin Ther
. 2008 Nov;
30(10):1817-30.
PMID: 19014837
Background: LC15-0444 is a selective inhibitor of dipeptidyl peptidase (DPP) IV under investigation in Korea for the treatment of type 2 diabetes. Objective: The aim of this study was to...
8.
Koo K, Kim M, Kim S, Kim K, Hong S, Hur G, et al.
Bioorg Med Chem Lett
. 2007 Jun;
17(15):4167-72.
PMID: 17544668
Synthesis of a novel series of DPPIV inhibitors with 1,2,4- and 1,3,4-oxadiazolyl ketone derivatives and its structure-activity relationships are discussed. Compound 18h showed good inhibitory activity against DPPIV and favorable...
9.
Lee K, Park C, Jung W, Park H, Lee S, Chung K, et al.
J Med Chem
. 2003 Aug;
46(17):3612-22.
PMID: 12904065
Thrombin, a crucial enzyme in the blood coagulation, has been a target for antithrombotic therapy. Orally active thrombin inhibitors would provide effective and safe prophylaxis for venous and arterial thrombosis....
10.
Lee K, Jung W, Park C, Park H, Lee S, Kwon O
Bioorg Med Chem Lett
. 2002 Mar;
12(7):1017-22.
PMID: 11909707
A series of noncovalent tripeptidic thrombin inhibitors incorporating amidrazone, amine and amidine functions at P1 was investigated. While the amidrazone and the amine series displayed limited oral absorption, the amidine...